GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM, 500-fold greater against a panel of 300 kinases.
For research use only. We do not sell to patients.
Name | GSK 2656157 |
---|---|
Iupac Chemical Name | 1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone |
Synonyms | GSK2656157 ; GSK 2656157 ; GSK-2656157 . |
Molecular Formula | C23H21FN6O |
Molecular Weight | 416.45 |
Smile | NC=1C2=C(N=CN1)N(C=C2C=2C(=C1CCN(C1=CC2)C(CC2=NC(=CC=C2)C)=O)F)C |
InChiKey | PRWSIEBRGXYXAJ-UHFFFAOYSA-N |
InChi | InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27) |
CAS Number | 1337532-29-2 |
Related CAS | 1337532-29-2 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder 6 months-80ºCin solvent |
Solubility | 5mg/ml in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | PERK Inhibitor |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |